Kapitalo Investimentos Ltda Bristol Myers Squibb CO Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$48.48 - $57.85 $122,460 - $146,129	-2,526 Reduced 30.57%	5,737 $294 Million
Q3 2023 Mar 29, 2024	BUY	$57.89 - $64.73 $367,254 - $410,647	6,344 Added 330.59%	8,263 $480 Million
Q2 2023 Mar 29, 2024	BUY	$63.71 - $70.74 $22,234 - $24,688	349 Added 22.23%	1,919 $123 Million
Q1 2023 Mar 29, 2024	BUY	$65.71 - $74.53 $103,164 - $117,012	1,570 New	1,570 $109 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.